2015
DOI: 10.1016/j.jvir.2015.07.024
|View full text |Cite
|
Sign up to set email alerts
|

Transcaval Aortic Access for Percutaneous Thoracic Aortic Aneurysm Repair: Initial Human Experience

Abstract: Transcaval aortic access has been used for deployment of transcatheter aortic valves in patients in whom conventional arterial approaches are not feasible. The present report describes its use for thoracic endovascular aortic repair (TEVAR) in a 61-year-old man with a descending thoracic aneurysm. Transcaval access was performed in lieu of a surgical iliac conduit in view of small atherosclerotic pelvic arteries. TEVAR was successfully performed, followed by intervascular tract occlusion with the use of a vent… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
27
0

Year Published

2017
2017
2024
2024

Publication Types

Select...
7
1

Relationship

2
6

Authors

Journals

citations
Cited by 27 publications
(28 citation statements)
references
References 9 publications
1
27
0
Order By: Relevance
“…Transcaval access is reported in only one thoracic endovascular aneurysm repair so far . In this reported case the TEVAR was performed successfully with a type I endoleaks that resolved in 1 week.…”
Section: Discussionmentioning
confidence: 80%
“…Transcaval access is reported in only one thoracic endovascular aneurysm repair so far . In this reported case the TEVAR was performed successfully with a type I endoleaks that resolved in 1 week.…”
Section: Discussionmentioning
confidence: 80%
“…It has been employed successfully as part of thoracic endovascular aneurysm repair (24) and to introduce 5.0 L percutaneous left ventricular assist devices ( Impella , Abiomed) (25). The transcaval approach may allow transcatheter implantation of other large devices, for example to treat aortic regurgitation.…”
Section: Discussionmentioning
confidence: 99%
“…Transcaval access has been applied to other applications, including large-bore percutaneous left ventricular assist devices for cardiogenic shock as well as thoracic endovascular aortic aneurysm repairs (1). Enrollment in the 100-subject National Heart, Lung, and Blood Institute–sponsored transcaval TAVR investigational device exemption protocol is now complete and results will be reported soon after follow-up is completed (NCT02280824).…”
mentioning
confidence: 99%